Literature DB >> 11976825

Lymphoid preponderance and the absence of basophilia and splenomegaly are frequent in m-bcr-positive chronic myelogenous leukemia.

M Hur1, E Y Song, S-H Kang, D-H Shin, J Y Kim, S S Park, H I Cho.   

Abstract

Chronic myelogenous leukemia (CML) with a minor bcr-abl transcript is a rare entity. We describe a 66-year-old female who was diagnosed with CML in the chronic phase. Molecular analysis of her Philadelphia chromosome using the reverse transcriptase polymerase chain reaction and subsequent sequencing revealed a minor bcr-abl transcript. Monocytosis resembling chronic myelomonocytic leukemia was observed without splenomegaly and basophilia. Her clinical course was indolent and maintained the chronic phase of CML for nearly 3 years under hydroxyurea treatment. A review of the 23 cases of m-bcr CML including this case showed the presence of monocytosis and the absence of basophilia and splenomegaly in 55.0%, 55.0%, and 70.0% of patients, respectively. The absence of basophilia was a significant finding in patients without monocytosis ( P=0.01). Although the hematological features or clinical outcomes were variable in m-bcr CML cases, all three cases at the onset of the blastic phase showed lymphoid crisis, implying an increased lymphoid leukemogenicity of minor bcr-abl transcripts.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11976825     DOI: 10.1007/s00277-002-0433-z

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  9 in total

1.  Chronic myeloid leukemia (CML) with P190 BCR-ABL: analysis of characteristics, outcomes, and prognostic significance.

Authors:  Dushyant Verma; Hagop M Kantarjian; Dan Jones; Rajyalakshmi Luthra; Gautam Borthakur; Srdan Verstovsek; Mary Beth Rios; Jorge Cortes
Journal:  Blood       Date:  2009-06-16       Impact factor: 22.113

2.  Characterization of p190-Bcr-Abl chronic myeloid leukemia reveals specific signaling pathways and therapeutic targets.

Authors:  Shady Adnan-Awad; Daehong Kim; Helena Hohtari; Komal Kumar Javarappa; Tania Brandstoetter; Isabella Mayer; Swapnil Potdar; Caroline A Heckman; Soili Kytölä; Kimmo Porkka; Eszter Doma; Veronika Sexl; Matti Kankainen; Satu Mustjoki
Journal:  Leukemia       Date:  2020-11-09       Impact factor: 11.528

3.  Childhood chronic myeloid leukemia with monocytosis.

Authors:  Nidhi Gupta; Ritu Gupta; Surender Kumar Sharawat; Sameer Bakhshi
Journal:  Indian J Pediatr       Date:  2010-09-30       Impact factor: 5.319

4.  Clinical and prognostic significance of e1a2 BCR-ABL1 transcript subtype in chronic myeloid leukemia.

Authors:  Z Gong; L J Medeiros; J E Cortes; L Zheng; J D Khoury; W Wang; G Tang; S Loghavi; R Luthra; W Yang; H M Kantarjian; S Hu
Journal:  Blood Cancer J       Date:  2017-07-14       Impact factor: 11.037

5.  T-cell blast crisis of chronic myelogenous leukemia presented with coexisting p210 and p190 BCR-ABL transcripts and t(10;11)(q11;p15).

Authors:  Ting Xia; Yuchao Yang; Guoxia Li; Jianmei Chang; Jianlan Li; Fanggang Ren; Weixiao Ren; Hongwei Wang; Zhifang Xu
Journal:  J Clin Lab Anal       Date:  2020-02-13       Impact factor: 2.352

6.  Chronic Myeloid Leukemia With P190 BCR-ABL Translocation and Persistent Moderate Monocytosis: A Case Report.

Authors:  Arianna Gatti; Alessandra Movilia; Lucia Roncoroni; Annalisa Citro; Sara Marinoni; Bruno Brando
Journal:  J Hematol (Brossard)       Date:  2018-09-01

7.  Chronic Myelogenous Leukemia with Double Philadelphia Chromosome and Coexpression of p210 and p190 Fusion Transcripts.

Authors:  Samara Silveira da Cruz; Aline Damasceno Seabra; Lais Helena Rescinho Macambira; Débora Monteiro Carneiro; Patrícia Ferreira Nunes; Thais Brilhante Pontes; Fernando Augusto Rodrigues Mello-Junior; Lucyana Barbosa Cardoso Leão; Fernanda de Nazaré Cardoso Dos Santos Cordeiro; Thiago Xavier Carneiro; Caroline Aquino Moreira-Nunes; Rommel Mario Rodríguez Burbano
Journal:  Genes (Basel)       Date:  2022-03-25       Impact factor: 4.096

8.  High incidence of minor and micro breakpoints in Chronic Myeloid Leukaemia with additional cytogenetic abnormalities at diagnosis - the Western Australian series.

Authors:  Emily Leung; Rebecca de Kraa; Alison Louw; Julian P Cooney
Journal:  Leuk Res Rep       Date:  2022-08-13

9.  Impact of the Breakpoint Region on the Leukemogenic Potential and the TKI Responsiveness of Atypical BCR-ABL1 Transcripts.

Authors:  Michele Massimino; Elena Tirrò; Stefania Stella; Livia Manzella; Maria Stella Pennisi; Chiara Romano; Silvia Rita Vitale; Adriana Puma; Cristina Tomarchio; Sandra Di Gregorio; Agostino Antolino; Francesco Di Raimondo; Paolo Vigneri
Journal:  Front Pharmacol       Date:  2021-06-30       Impact factor: 5.810

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.